The bankruptcy of genetic-testing pioneer 23andMe is a powerful cautionary tale. After going public in 2021 with a $3.5 billion valuation, the company’s market cap plummeted to less than $13.5 million ...
Genetic epidemiology examines the effect of genetic variation on a disease or a health-related outcome. Since 2007, genome wide association studies have been widely used to detect associations between ...